Anzemet and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Breast cancer.

The phase IV clinical study analyzes which people have Post procedural complication when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,089 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.

On Jul, 13, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 13 people (0.51%) have Post procedural complication.

Could Anzemet cause Post procedural complication?

Among these 13 people:

How long have people been on Anzemet when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Anzemet? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Post procedural complication when taking Anzemet? *

What are other drugs people take besides Anzemet? *

What are other side effects people have besides Post procedural complication? *

High Blood Pressure: 3 people, 23.08%
Dehydration (dryness resulting from the removal of water): 3 people, 23.08%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 23.08%
Abdominal Pain: 2 people, 15.38%
Depression: 2 people, 15.38%
Cardiac Arrest: 2 people, 15.38%
Oedema Peripheral (superficial swelling): 2 people, 15.38%
Haematochezia (passage of stools containing blood): 2 people, 15.38%
Nausea And Vomiting: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%

What are the existing conditions these people have? *

Colon Cancer: 2 people, 15.38%
Breast Cancer: 2 people, 15.38%
Pain: 1 person, 7.69%
Ovarian Cancer (cancer of ovary): 1 person, 7.69%
Neoplasm Malignant (cancer tumour): 1 person, 7.69%
Migraine (headache): 1 person, 7.69%
Hot Flush (sudden feelings of heat): 1 person, 7.69%
Heart Rate Increased: 1 person, 7.69%
Granulocyte Count Decreased: 1 person, 7.69%
Discomfort: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Anzemet (2,603 reports)

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,089 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.